To develop models to predict vaginal delivery in low-risk, nulliparous women contemplating elective induction of labor (IOL) versus expectant management (EM) at 39 weeks gestation. STUDY DESIGN: Secondary analysis of a RCT of planned IOL at 39 weeks versus EM for low-risk nulliparous women. Two sub-cohorts were included for this analysis: 1) women who were randomized to the IOL group who had an elective induction 39 0 -39 4 weeks gestation and 2) women who were randomized to the EM group who had spontaneous labor or medically indicated delivery (including postdates). Multivariable logistic regression models were developed for each cohort using patient characteristics that would be available at the time of counseling. Variables that remained significant at p<0.05 were retained in the model. In order to compare estimated to observed rates, the IOL model was then applied to each women in both cohorts to estimate individualized predicted probabilities of vaginal delivery if she was to have IOL. Deciles of predicted probabilities of vaginal delivery associated with IOL were then plotted against the actual percent vaginal delivery observed in each cohort using locally weighted scatterplot smoothing. RESULTS: Of 6,106 women enrolled in the trial, 4,661 met criteria for this analysis. Vaginal delivery occurred in 80.6% of the 2,153 women in the IOL group and 77.2% of the 2,508 women in the EM group. The final IOL model included age, height, weight, and modified Bishop score (area under the curve ¼ 0.70 (95%CI 0.68-0.73)). The same variables, as well as assisted conception, were included in the final EM model (area under the curve ¼ 0.72 (95%CI 0.69-0.74)). Across the range of predicted probability deciles derived from the IOL model, women who actually underwent IOL at 39 weeks had a higher observed chance of vaginal delivery than those who actually underwent EM (figure). Examples of personalized probabilities for vaginal birth with IOL and EM, based on their cohort-specific model, are depicted across scenarios (table) . CONCLUSION: Irrespective of the individual predicted chance of vaginal delivery from IOL at 39 weeks, the actual occurrence of vaginal delivery is largely higher if IOL is undertaken rather than EM. Given the variance in individual feelings and beliefs about labor induction, these data can be used to counsel nulliparous women regarding their "personalized" chances of vaginal delivery as they choose between IOL or EM at 39 weeks gestation. 
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To develop models to predict vaginal delivery in low-risk, nulliparous women contemplating elective induction of labor (IOL) versus expectant management (EM) at 39 weeks gestation. STUDY DESIGN: Secondary analysis of a RCT of planned IOL at 39 weeks versus EM for low-risk nulliparous women. Two sub-cohorts were included for this analysis: 1) women who were randomized to the IOL group who had an elective induction 39 0 -39 4 weeks gestation and 2) women who were randomized to the EM group who had spontaneous labor or medically indicated delivery (including postdates). Multivariable logistic regression models were developed for each cohort using patient characteristics that would be available at the time of counseling. Variables that remained significant at p<0.05 were retained in the model. In order to compare estimated to observed rates, the IOL model was then applied to each women in both cohorts to estimate individualized predicted probabilities of vaginal delivery if she was to have IOL. Deciles of predicted probabilities of vaginal delivery associated with IOL were then plotted against the actual percent vaginal delivery observed in each cohort using locally weighted scatterplot smoothing. RESULTS: Of 6,106 women enrolled in the trial, 4,661 met criteria for this analysis. Vaginal delivery occurred in 80.6% of the 2,153 women in the IOL group and 77.2% of the 2,508 women in the EM group. The final IOL model included age, height, weight, and modified Bishop score (area under the curve ¼ 0.70 (95%CI 0.68-0.73)). The same variables, as well as assisted conception, were included in the final EM model (area under the curve ¼ 0.72 (95%CI 0.69-0.74)). Across the range of predicted probability deciles derived from the IOL model, women who actually underwent IOL at 39 weeks had a higher observed chance of vaginal delivery than those who actually underwent EM (figure). Examples of personalized probabilities for vaginal birth with IOL and EM, based on their cohort-specific model, are depicted across scenarios (table) . CONCLUSION: Irrespective of the individual predicted chance of vaginal delivery from IOL at 39 weeks, the actual occurrence of vaginal delivery is largely higher if IOL is undertaken rather than EM. Given the variance in individual feelings and beliefs about labor induction, these data can be used to counsel nulliparous women regarding their "personalized" chances of vaginal delivery as they choose between IOL or EM at 39 weeks gestation. OBJECTIVE: Labor induction occurs in over 20% of pregnancies in the United States. There is evidence that induction reduces the chances of successful VBAC. What is unknown however is whether the induction indication has a specific influence on success. We sought to evaluate the association between specific induction indication on TOLAC success. STUDY DESIGN: This was a retrospective cohort study of all patients undergoing TOLAC at a single academic tertiary care center between January 2011 and May 2018. Data were collected via individual chart review and analyzed by indication for induction. Comparison groups included elective, post-dates (41 weeks), fetal indication (non-reassuring testing, growth restriction, or oligohydramnios), maternal indication (hypertension or diabetes mellitus), and other indication. The primary outcome was VBAC success. Secondary outcomes included maternal composite morbidity and mortality (uterine rupture, hemorrhage, transfusion, ICU admission, cesarean hysterectomy, or death) and neonatal composite morbidity and mortality (5 minute APGAR < 7, arterial cord pH < 7, NICU admission, hypoxic ischemic encephalopathy, and death). RESULTS: Of the 1397 patients studied, 520 underwent labor induction. There was a significant difference in BMI and black race between induction indications; otherwise, there were no differences in demographic characteristics between the groups. VBAC success rate ranged from 60.0 -70.1%, p¼.062. There were no significant differences in the rates of VBAC success between groups (p¼0.602).
Maternal and neonatal composite morbidity and mortality were not significantly different amongst the groups. CONCLUSION: We did not observe any significant associations between induction indication and VBAC success in our cohort.
797 Exosome contribution to feto-maternal signals that induce preterm labor in mice
The University of Texas Medical Branch, Galveston, TX OBJECTIVE: Endocrine signaling is important to determine the timing of labor at term and preterm. Recent reports suggest exosomes can also act as signals between feto-maternal tissues. The objective of this study was to determine the role of exosomes in promoting parturition in animal models of pregnancy. STUDY DESIGN: Maternal plasma exosomes from CD-1 mice were isolated and characterized (size, shape, quantity, markers and cargo) throughout gestation using cryo electron microscopy, nanoparticle tracking analysis, Western blot and proteomics. Biological pathways associated with differentially-expressed cargo proteins were determined throughout gestation. To determine the role of early (E9) and late (E18) gestation exosomes in preterm birth (PTB), intraperitoneal injections of E9 or E18 exosomes (3.33-9.16 x 10 10 ) were performed on E15. Exosomes were labeled with carboxyfluorescein succinimidyl ester (CFSE) prior to injection and maternal (uterus, cervix) and fetal (placenta, fetal membranes) tissues were imaged for
